Echofos Medical is an early stage start-up company based in Toronto, Ontario, founded in 2013.
Our mission is to create a device that detects circulating tumour cells (CTCs) in the blood.
– 90% of cancer-associated deaths are due to metastasis.
– CTCs are approved by the FDA to use for prognosis of major cancers such as breast, prostate, and colon.
Detection of CTCs in blood can aid in prognosis of overall survival as well as treatment monitoring. Our diagnostic device works using sound to detect physical properties that are unique to cancer cells.